MAPT and Alzheimer disease: Not only does [18F]GTP1 retention correspond to established patterns of brain tau distribution in AD, but this new second‐generation tau tracer was also correlated with performance on cognitive measures, particularly in the earliest stages of AD (Bohórquez et al., 2019; Teng et al., 2018; Teng et al., 2019).